Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Scientific Reports
|
August 1, 2025
Multihop cost awareness task migration with networking load balance technology for vehicular edge computing
Shih-Yang Lin, Jie-Qin Wang, Shi-Ming Peng, et al.
International Journal of Biological Sciences
|
March 17, 2020
Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
Hua-Dong Chen, Chen-Song Huang, Qiong-Cong Xu, et al.
Advanced Healthcare Materials
|
December 27, 2025
Synergistic Induction of Ferroptosis by GPX4 Inhibitor and GSH-Depleted Nanoparticles Effectively Reverses Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma PDX Model
Chen-Song Huang, Chunlei Dai, Qi Liu, et al.
Cancer Science
|
August 7, 2019
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552
Xiao-Xu Zhu, Jian-Hui Li, Jian-Peng Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 11, 2020
Targeting Super-Enhancers via Nanoparticle-Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma
Chen-Song Huang, Xinru You, Chunlei Dai, et al.
Nanoscale
|
July 31, 2020
Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapy
Jie-Qin Wang, Li-Ying Wang, Shi-Jin Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 29, 2019
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 17, 2022
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer
Yin-Hao Shi, Qiong-Cong Xu, Ying-Qin Zhu, et al.
Oncogene
|
June 24, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Ying-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Scientific Reports
|
August 1, 2025
Multihop cost awareness task migration with networking load balance technology for vehicular edge computing
Shih-Yang Lin, Jie-Qin Wang, Shi-Ming Peng, et al.
International Journal of Biological Sciences
|
March 17, 2020
Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
Hua-Dong Chen, Chen-Song Huang, Qiong-Cong Xu, et al.
Advanced Healthcare Materials
|
December 27, 2025
Synergistic Induction of Ferroptosis by GPX4 Inhibitor and GSH-Depleted Nanoparticles Effectively Reverses Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma PDX Model
Chen-Song Huang, Chunlei Dai, Qi Liu, et al.
Cancer Science
|
August 7, 2019
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552
Xiao-Xu Zhu, Jian-Hui Li, Jian-Peng Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 11, 2020
Targeting Super-Enhancers via Nanoparticle-Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma
Chen-Song Huang, Xinru You, Chunlei Dai, et al.
Nanoscale
|
July 31, 2020
Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapy
Jie-Qin Wang, Li-Ying Wang, Shi-Jin Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 29, 2019
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 17, 2022
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer
Yin-Hao Shi, Qiong-Cong Xu, Ying-Qin Zhu, et al.
Oncogene
|
June 24, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Ying-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.
Page
of 2